IFP Advisors’s Aethlon Medical AEMD Stock Holding History

IFP Advisors’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-136	Closed	-$9.38K	–	4300
2024 Q4	$9.38K	Buy	+136	New	+$4.62K	﹤0.01%	2547

Other funds holding AEMD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

AFGAS

Allegiance Financial Group Advisory Services Vienna, Virginia $503M AUM 22.39% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

IFP Advisors's AEMD Position: Q1 2025 in Review

IFP Advisors sold out of Aethlon Medical (AEMD) in Q1 2025, closing a stake of 136 shares — an estimated $9.38K sold.

IFP Advisors first reported a position in AEMD in Q4 2024 and held it in 1 quarter. The position peaked at $9.38K in Q4 2024. 19 funds tracked by Wall St. Rank hold AEMD as of Q1 2025.

IFP Advisors reported no remaining Aethlon Medical position as of Q1 2025 after selling out during the quarter.
IFP Advisors sold 136 Aethlon Medical shares in Q1 2025, an estimated $9.38K.
IFP Advisors first reported a position in Aethlon Medical in Q4 2024 and held it in 1 quarter.
IFP Advisors's Aethlon Medical position peaked at $9.38K in Q4 2024.
19 funds tracked by Wall St. Rank held Aethlon Medical as of Q1 2025.

Based on IFP Advisors's 13F filing for Q1 2025, filed 5 May 2025.